|
|
.
See Category: Diseases of the skin and subcutaneous tissue
ICD-10 (CM) Code and Descriptor
L508 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 58.10%
|
14.46%
|
7.57%
|
5.68%
|
3.67%
|
2.97%
|
1.85%
|
1.35%
|
1.01%
|
0.67%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for L50.8*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
3,723
|
5,212
|
|
J2357
|
OMALIZUMAB INJECTION |
3,256
|
175,705
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,541
|
1,542
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
986
|
990
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
797
|
798
|
|
80053
|
COMPREHEN METABOLIC PANEL |
648
|
648
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
512
|
512
|
|
86003
|
ALLG SPEC IGE CRUDE XTRC EA |
467
|
4,094
|
|
84443
|
ASSAY THYROID STIM HORMONE |
454
|
456
|
|
85652
|
RBC SED RATE AUTOMATED |
285
|
285
|
|
83520
|
IMMUNOASSAY QUANT NOS NONAB |
280
|
304
|
|
86038
|
ANTINUCLEAR ANTIBODIES |
259
|
259
|
|
99283
|
EMERGENCY DEPT VISIT LOW MDM |
255
|
257
|
|
82785
|
ASSAY OF IGE |
239
|
240
|
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
231
|
305
|
|
G0467
|
FQHC VISIT, ESTAB PT |
230
|
230
|
|
86376
|
MICROSOMAL ANTIBODY EACH |
222
|
598
|
|
86160
|
COMPLEMENT ANTIGEN |
218
|
327
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
214
|
214
|
|
86140
|
C-REACTIVE PROTEIN |
203
|
203
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
L50.8 related to the following DRG Codes:
606-607
|
